Tag: Post marketing surveillance

Adverse drug reactions (ADRs) are a major public health concern, with some estimates suggesting they are the 4th leading cause of death in the U.S., ahead of diabetes and accidents [1.4.1]. To protect public health, regulatory bodies and pharmaceutical companies use two primary methods to monitor drug safety. So, **what are the two types of pharmacovigilance?** They are active and passive surveillance [1.2.2].

In 2022, over 1.25 million serious adverse drug events were reported to the FDA, including nearly 175,000 deaths. This highlights the critical need for pharmacovigilance, the science devoted to monitoring, detecting, and preventing adverse effects of medicines to ensure patient safety.